Response Oncology Price on April 10, 2023
If you're considering investing in Response Stock, it is important to understand the factors that can impact its price. We have found zero technical indicators for Response Oncology, which you can use to evaluate the volatility of the company.
Response Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Response |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ROIX |
Based on monthly moving average Response Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Response Oncology by adding Response Oncology to a well-diversified portfolio.
Response Oncology Valuation on April 10, 2023
It is possible to determine the worth of Response Oncology on a given historical date. On April 10, 2023 Response was worth 0.0 at the beginning of the trading date compared to the closed value of 0.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Response Oncology stock. Still, in general, we apply an absolute valuation method to find Response Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Response Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Response Oncology's related companies.
| Open | High | Low | Close | Volume | |
04/10/2023 | 0.00 | 0.00 | 0.00 | 0.00 | 500.00 |
| 0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
| Backtest Response Oncology | | | Response Oncology History | | | Response Oncology Valuation | Next |
Response Oncology Trading Date Momentum on April 10, 2023
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Response Oncology Fundamentals Correlations and Trends
By evaluating Response Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Response Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Response financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Response Oncology Stock history
Response Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Response is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Response Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Response Oncology stock prices may prove useful in developing a viable investing in Response Oncology
Response Oncology, Inc. does not have significant operations. Prior to the sale of its assets, it provided advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists owned the assets of and managed the nonmedical aspects of oncology practices compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee and conducted outcomes research on behalf of pharmaceutical manufacturers. Response Oncology is traded on OTC Exchange in the United States.
Response Oncology Stock Technical Analysis
Response Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Response Oncology Period Price Range
Low | December 19, 2024
| High |
0.00 | 0.00 |
Response Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Response Oncology December 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Response Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Response Oncology shares will generate the highest return on investment. By undertsting and applying Response Oncology stock market strength indicators, traders can identify Response Oncology entry and exit signals to maximize returns
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Response Stock
If you are still planning to invest in Response Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Response Oncology's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |